Built on the CaredFor Patient Engagement platform, AAC Together enables AAC to extend recovery support beyond discharge and into daily life. Through the app, alumni across AAC's nationwide network of ...
A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.
DETROIT (WXYZ) — For many people, the holidays represent the most wonderful time of the year. But for those recovering from substance abuse, this season can be the ...
COLUMBUS, Ohio, April 22, 2025 /PRNewswire/ -- Eating Protein Saves Lives, Inc. announces the release of EAT!: A Guide to Radiant Recovery Using Food and Amino Acids to Repair the Addicted Brain and ...
In Philadelphia, over 1,170 people died of opioid overdoses in 2022, the last year for which complete data is available. More than 300 more died just over the bridge in Camden County. Research ...
The popular class of weight loss drugs known as GLP-1s have shown to be effective in curbing cravings beyond food. A few early studies have suggested that GLP-1 medications can do a lot to alleviate ...
Relapse isn’t a failure. It’s a signal. It tells us that something deeper is still driving our old behaviors. For decades, I’ve studied the science of addiction, relapse, and behavior change through ...
A medication currently used to treat diabetes and obesity may offer a new way to help people struggling with alcohol addiction. A recent study published in eBioMedicine found that the drug tirzepatide ...
Relapse prevention is why most people seek treatment, and with opioid use disorders (OUDs), there’s about a 90 percent relapse rate. This article explains why and how specific sayings from self-help ...
Add Yahoo as a preferred source to see more of our stories on Google. Neuroscientists are investigating how and when hormones affect the risk for relapse to prescription opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results